Induction of apoptosis by cerebrospinal fluid from patients with primary-progressive multiple sclerosis in cultured neurons

被引:29
|
作者
Alcázar, A
Regidor, I
Masjuan, J
Salinas, M
Alvarez-Cermeño, JC
机构
[1] Hosp Ramon & Cajal, Serv Neurol, E-28034 Madrid, Spain
[2] Hosp Ramon & Cajal, Dept Invest, E-28034 Madrid, Spain
[3] Univ Alcala de Henares, Dept Med, Alcala De Henares, Spain
关键词
multiple sclerosis; primary-progressive multiple sclerosis; apoptosis; cultured neurons;
D O I
10.1016/S0304-3940(98)00708-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We have studied the noxious effect of cerebrospinal fluids (CSF) from patients with primary-progressive multiple sclerosis (MS) on cultured neurons. Cells were exposed to CSF for 8 days and the possible neuronal damage was determined. Morphological studies with phase-contrast microscopy showed cellular shrinkage indicating apoptosis. CSF-induced apoptosis as evidenced by the fluorescent DNA-binding dye Hoechst 33342, as well as by the TUNEL-reaction, was only present in primary-progressive MS patients with a worsening disease. This neuron injury did not correlate with blood-brain barrier dysfunction nor with intrathecal IgG synthesis. On the contrary, CSF from either stable primary-progressive or other non-inflammatory neurological diseases, did not induce any culture damage. Undetectable or low similar tumor necrosis factor-alpha (TNF-alpha) levels (range to 8.7 pg/ml) were found in the CSFs tested regardless they damage cultures or not. These results suggest that soluble factors, other than TNF-alpha, molecules transudated from blood or IgG, present in the CSF of active primary-progressive patients with MS induce neuronal apoptosis. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:75 / 78
页数:4
相关论文
共 50 条
  • [1] Primary-progressive multiple sclerosis
    Miller, David H.
    Leary, Siobhan M.
    [J]. LANCET NEUROLOGY, 2007, 6 (10): : 903 - 912
  • [2] A new model for primary-progressive multiple sclerosis?
    Waisman, Ari
    Regen, Tommy
    [J]. ACTA NEUROPATHOLOGICA, 2013, 126 (04) : 519 - 521
  • [3] Apoptosis of cerebrospinal fluid lymphocytes in patients with relapsing-remitting, primary and secondary progressive multiple sclerosis
    Petelin, Z
    Brinar, V
    Zurak, N
    Dubravcic, K
    Botinic, D
    Ivankovic, D
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2005, 11 : S125 - S126
  • [4] A new model for primary-progressive multiple sclerosis?
    Ari Waisman
    Tommy Regen
    [J]. Acta Neuropathologica, 2013, 126 : 519 - 521
  • [5] Primary progressive multiple sclerosis: cerebrospinal fluid considerations
    Freedman, MS
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2004, 10 : S31 - S34
  • [6] Looking into cognitive impairment in primary-progressive multiple sclerosis
    Petracca, M.
    Sumowski, J.
    Fabian, M.
    Miller, A.
    Lublin, F.
    Inglese, M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (01) : 192 - 195
  • [7] Descriptive study of a primary-progressive multiple sclerosis population
    Landete Pascual, L.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S161 - S162
  • [8] Cerebrospinal fluid immunoglobulins in primary progressive multiple sclerosis are pathogenic
    Wong, Jamie K.
    Lin, Jerry
    Kung, Nathan J.
    Tse, Alexandra L.
    Shimshak, Serena J. E.
    Roselle, Anna K.
    Cali, Francesca M.
    Huang, Jessie
    Beaty, Joseph M.
    Shue, Taylor M.
    Sadiq, Saud A.
    [J]. BRAIN, 2023, 146 (05) : 1979 - 1992
  • [9] Disability accrual in primary-progressive & secondary-progressive multiple sclerosis
    Harding-Forrester, S.
    Roos, I.
    Sharmin, S.
    Diouf, I.
    Malpas, C.
    Nguyen, A. -L.
    Moradi, N.
    Horakova, D.
    Havrdova, E. Kubala
    Patti, F.
    Izquierdo, G.
    Eichau, S.
    Prat, A.
    Girard, M.
    Duquette, P.
    Onofrj, M.
    Lugaresi, A.
    Grand'Maison, F.
    Weinstock-Guttman, B.
    Amato, M. P.
    Grammond, P.
    Gerlach, O.
    Ozakbas, S.
    Sola, P.
    Ferraro, D.
    Butzkueven, H.
    Lechner-Scott, J.
    Boz, C.
    Alroughani, R.
    Van Pesch, V.
    Cartechini, E.
    Terzi, M.
    Maimone, D.
    Ramo-Tello, C.
    Spitaleri, D.
    Kappos, L.
    Yamout, B.
    Sa, M.
    Slee, M.
    Blanco, Y.
    Bergamaschi, R.
    Butler, E.
    Iuliano, G.
    Granella, F.
    Sidhom, Y.
    Gouider, R.
    Ampapa, R.
    Van Wijmeersch, B.
    Karabudak, R.
    Prevost, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 527 - 528
  • [10] Cerebrospinal fluid biomarkers of early worsening in primary progressive multiple sclerosis
    Emersic, A.
    Brecl-Jakob, G.
    Sega-Jazbec, S.
    Horvat-Ledinek, A.
    Cucnik, S.
    Rot, U.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 828 - 828